Top

Published in:

01-11-2020 | Colchicine | CE-Research Letter to the Editor

Characteristics and outcomes of Behçet’s syndrome patients with Coronavirus Disease 2019: a case series of 10 patients

Authors: Berna Yurttaş, Mert Oztas, Ali Tunc, İlker İnanç Balkan, Omer Fehmi Tabak, Vedat Hamuryudan, Emire Seyahi

Published in: Internal and Emergency Medicine | Issue 8/2020

Excerpt

Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is the cause of the global pandemic that originated in China in December 2019 [1]. It had spread all over Turkey in March 2020, Istanbul being hit the hardest. As of 28 May 2020, the total number of confirmed cases in the country is over 161,000 of which 124,400 have recovered and 4500 have died [2]. …

WHO (2020) Novel coronavirus—China. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/. Accessed 19 Jan 2020

https://covid19.saglik.gov.tr. Accessed 23 May 2020

Gandhi RT, Lynch JB, Del Rio C (2020) Mild or moderate Covid-19. N Engl J Med. https://doi.org/10.1056/NEJMcp2009249CrossRefPubMedPubMedCentral

Klok FA, Kruip MJHA, van der Meer NJM et al (2020) Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. https://doi.org/10.1016/j.thromres.2020.04.041(published online ahead of print, 2020 Apr 30)CrossRefPubMedPubMedCentral

Lodigiani C, Iapichino G, Carenzo L et al (2020) Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 191:9–14 (published online ahead of print, 2020 Apr 23)CrossRefPubMedPubMedCentral

Helms J, Tacquard C, Severac F et al (2020) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. https://doi.org/10.1007/s00134-020-06062-x(published online ahead of print, 2020 May 4)CrossRefPubMedPubMedCentral

Middeldorp S, Coppens M, van Haaps TF et al (2020) Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. https://doi.org/10.1111/jth.14888(published online ahead of print, 2020 May 5)CrossRefPubMedPubMedCentral

Michelena X, Borrell H, López-Corbeto M et al (2020) Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs. Semin Arthritis Rheum 50(4):564–570. https://doi.org/10.1016/j.semarthrit.2020.05.001(published online ahead of print, 2020 May 16)CrossRefPubMedPubMedCentral

Emmi G, Bettiol A, Mattioli I et al (2020) SARS-CoV-2 infection among patients with systemic autoimmune diseases. Autoimmun Rev 19(7):102575. https://doi.org/10.1016/j.autrev.2020.102575CrossRefPubMedPubMedCentral

10.

Yazici H, Seyahi E, Hatemi G, Yazici Y (2018) Behçet syndrome: a contemporary view. Nat Rev Rheumatol 14(2):107–119. https://doi.org/10.1038/nrrheum.2017.208(published correction appears in Nat Rev Rheumatol. 2018 Jan 24;14 (2):119)CrossRefPubMed

11.

Seyahi E (2019) Phenotypes in Behçet's syndrome. Intern Emerg Med 14(5):677–689. https://doi.org/10.1007/s11739-019-02046-yCrossRefPubMed

12.

Esatoglu SN, Hatemi G (2019) Update on the treatment of Behçet's syndrome. Intern Emerg Med 14(5):661–675. https://doi.org/10.1007/s11739-019-02035CrossRefPubMed

13.

https://hsgm.saglik.gov.tr/depo/birimler/goc_sagligi/covid19/rehber/COVID-19_Rehberi20200414_eng_v4_002_14.05.2020.pdf

14.

Fang Y, Zhang H, Xie J et al (2020) Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. https://doi.org/10.1148/radiol.2020200432(published online ahead of print, 2020 Feb 19)CrossRefPubMed

15.

Ye C, Cai S, Shen G et al (2020) Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-217627(published online ahead of print, 2020 May 22)CrossRefPubMed

16.

Verdoni L, Mazza A, Gervasoni A et al (2020) An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. https://doi.org/10.1016/S0140-6736(20)31103-X(published online ahead of print, 2020 May 13)CrossRefPubMedPubMedCentral

17.

Ackermann M, Verleden SE, Kuehnel M et al (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. https://doi.org/10.1056/NEJMoa2015432(published online ahead of print, 2020 May 21)CrossRefPubMedPubMedCentral

18.

Latif F, Farr MA, Clerkin KJ et al (2020) Characteristics and outcomes of recipients of heart transplant with coronavirus disease 2019. JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.2159(Epub ahead of print)CrossRefPubMedPubMedCentral

19.

Deftereos S, Giannopoulos G, Vrachatis DA et al (2020) Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks? Eur Heart J Cardiovasc Pharmacother. https://doi.org/10.1093/ehjcvp/pvaa033(published online ahead of print, 2020 Apr 27)CrossRefPubMed

Title: Characteristics and outcomes of Behçet’s syndrome patients with Coronavirus Disease 2019: a case series of 10 patients
Authors: Berna Yurttaş
Mert Oztas
Ali Tunc
İlker İnanç Balkan
Omer Fehmi Tabak
Vedat Hamuryudan
Emire Seyahi
Publication date: 01-11-2020
Publisher: Springer International Publishing
Keywords: Colchicine
Phlebothrombosis
COVID-19
CT of the Thorax
Published in: Internal and Emergency Medicine / Issue 8/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-020-02427-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2020

Cause-specific death in hospitalized individuals infected with SARS-CoV-2: more than just acute respiratory failure or thromboembolic events

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies: comment

COVID-19 pandemic and Internal Medicine Units in Italy: a precious effort on the front line

The COVID-19 epidemic and reorganisation of triage, an observational study

How cardiologists respond to COVID-19: the experience of West China Hospital, China

A woman with fever and cough: coronavirus disease 2019

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials